Tino Hochepied Selected Research

Tino Hochepied Research Topics

Disease

7	Inflammation (Inflammations) 01/2023 - 10/2004
4	Neoplasms (Cancer) 04/2022 - 04/2011
4	Carcinogenesis 10/2021 - 04/2011
3	Shock 10/2020 - 02/2006
1	Glucocorticoid Receptor Deficiency 01/2023
1	Sepsis (Septicemia) 01/2023
1	Anorexia 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	autosomal recessive 1 Spinocerebellar ataxia 10/2022
1	Dermatitis 10/2021
1	Lymphoma (Lymphomas) 10/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2021
1	Infections 10/2021
1	Moyamoya Disease (Moya-Moya Disease) 10/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Crohn Disease (Crohn's Disease) 10/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2018
1	Bloom Syndrome 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Distal Myopathies (Distal Muscular Dystrophy) 01/2018
1	Cholangiocarcinoma 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Familial Mediterranean Fever (Periodic Disease) 12/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2016
1	Type 2F Charcot-Marie-Tooth disease 01/2016
1	Necrosis 10/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2015
1	Amyloidosis 05/2015
1	Acute Kidney Injury (Acute Renal Failure) 10/2004
1	Reperfusion Injury 10/2004
1	Asthma (Bronchial Asthma) 07/2004
1	Arthritis (Polyarthritis) 07/2004

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2011
3	CytokinesIBA 10/2021 - 12/2016
3	InterferonsIBA 10/2021 - 10/2020
2	LuciferasesIBA 01/2023 - 01/2019
2	CollagenIBA 04/2022 - 01/2021
2	GlucocorticoidsIBA 01/2022 - 12/2016
2	Peptide Hydrolases (Proteases)FDA Link 10/2021 - 01/2019
2	Small Heat-Shock ProteinsIBA 01/2018 - 01/2016
2	InflammasomesIBA 12/2017 - 12/2016
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2023
1	PPAR alphaIBA 01/2023
1	Amino Acids FDA Link 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Apoptosis Regulatory ProteinsIBA 01/2023
1	Nonesterified Fatty Acids (NEFA)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Glycerol (Glycerine)FDA LinkGeneric 01/2023
1	Ketone BodiesIBA 01/2023
1	NucleotidesIBA 10/2022
1	Protein Isoforms (Isoforms)IBA 04/2022
1	ProtocadherinsIBA 04/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2021
1	Phosphotransferases (Kinase)IBA 10/2021
1	Cyclin D2IBA 10/2021
1	CyclinsIBA 10/2021
1	UbiquitinsIBA 10/2021
1	EnzymesIBA 01/2021
1	ZincIBA 10/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2020
1	Tetracycline (Achromycin)FDA LinkGeneric 06/2019
1	Doxycycline (Periostat)FDA LinkGeneric 06/2019
1	Trans-Activators (Trans-Acting Factor)IBA 06/2019
1	ML216IBA 01/2018
1	DNA HelicasesIBA 01/2018
1	polyglutamineIBA 01/2018
1	anthraceneIBA 01/2017
1	PyrinIBA 12/2016
1	Imiquimod (Aldara)FDA LinkGeneric 12/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2015
1	Heme (Haem)IBA 10/2015
1	Soluble Guanylyl CyclaseIBA 10/2015
1	BAY 58-2667IBA 10/2015
1	GelsolinIBA 05/2015
1	Amyloid (Amyloid Fibrils)IBA 05/2015
1	Oncogene Proteins (Oncogene Protein)IBA 04/2011
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2011
1	LigandsIBA 02/2006
1	Toll-Like Receptor 4IBA 02/2006
1	FucoseIBA 10/2004
1	Glycoproteins (Glycoprotein)IBA 10/2004
1	OvalbuminIBA 07/2004

Therapy/Procedure

3	Therapeutics 06/2019 - 04/2011
1	Punctures 01/2023
1	Ligation 01/2023
1	Controlled Hypotension 10/2015
1	Transplantation 10/2004